Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proof of Concept Evaluation of Drug-Device Interaction with aclidinium via Genuair and tiotropium via HandiHaler in COPD
2013-003594-99Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of aclidinium and tiotropium in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by University of Dundee. Primary endpoint: Change in trough R5 from baseline after chronic dosing. Started Dec 2013; status: completed.
02
Drugs
aclidiniumtiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2013-003594-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003594-99.